Department of Cardiovascular Surgery, Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, Houston, Tex 77030, USA.
J Vasc Surg. 2010 Jan;51(1):259-66. doi: 10.1016/j.jvs.2009.09.043. Epub 2009 Dec 2.
Thoracic endovascular aortic repair (TEVAR) can be limited by inadequate proximal and distal landing zones. Debranching or hybrid TEVAR has emerged as an important modality to expand landing zones and facilitate TEVAR. We report a single-center experience with hybrid TEVAR.
We retrospectively reviewed all patients with thoracic aortic disease who received a TEVAR between February 2005 and October 2008.
Forty-two patients underwent a hybrid procedure (mean age 68 +/- 13 years; 55% men). All patients were denied open surgery due to preoperative comorbidities or low physiologic reserve; 62% had a history of coronary artery disease, 67% had chronic obstructive pulmonary disease, 61% had undergone prior aortic surgery, and 90% had an American Society of Anesthesiology score of 4 and above. The average Society for Vascular Surgery comorbidity score was 12 +/- 2 with a range of 9 to 14. Fifty-five percent of cases were symptomatic on presentation and 83% were done emergently. Seventy-six percent underwent debranching of the aortic arch, 17% of the visceral vessels, and 7% required both. Primary technical success was achieved in all cases and of these, 43% were staged. The 30-day mortality was 5%. Myocardial infarction developed in 5%, respiratory failure in 31%, cerebrovascular accident (stroke or transient ischemic attack) in 19%, and spinal cord ischemia with ensuant paraplegia occurred in 5% of patients. Fifty-eight percent of patients were discharged home, 11% required rehabilitation, and 29% were transferred to a skilled nursing facility. There was a significant association between visceral vessel debranching and both spinal cord ischemia (P = .004) and gastrointestinal complications (P = .005). On the other hand, there was no difference between staged and non-staged hybrid procedures.
Hybrid procedures can successfully extend the range of patients suitable for a subsequent TEVAR. These procedures are associated with higher complication rates than isolated infrarenal or thoracic endovascular repair, but given the medical and anatomical complexity of these patients, the current results are quite encouraging.
胸主动脉腔内修复术(TEVAR)可能受到近端和远端着陆区不足的限制。分支重建或杂交 TEVAR 已成为扩大着陆区和促进 TEVAR 的重要方式。我们报告了单中心杂交 TEVAR 的经验。
我们回顾性分析了 2005 年 2 月至 2008 年 10 月间接受 TEVAR 的所有胸主动脉疾病患者。
42 例患者接受了杂交手术(平均年龄 68±13 岁;55%为男性)。所有患者均因术前合并症或低生理储备而被拒绝开放手术;62%有冠心病史,67%有慢性阻塞性肺疾病,61%有主动脉手术史,90%有美国麻醉医师协会评分 4 分及以上。平均血管外科学会合并症评分为 12±2,范围为 9 至 14。55%的病例在就诊时出现症状,83%为紧急情况。76%的患者进行了主动脉弓分支重建,17%的内脏血管,7%的患者需要同时进行。所有病例均实现了主要技术成功,其中 43%为分期手术。30 天死亡率为 5%。5%的患者发生心肌梗死,31%发生呼吸衰竭,19%发生脑血管意外(中风或短暂性脑缺血发作),5%的患者发生脊髓缺血伴随后遗截瘫。58%的患者出院回家,11%需要康复,29%转至专业护理机构。内脏血管分支重建与脊髓缺血(P=0.004)和胃肠道并发症(P=0.005)之间存在显著关联。另一方面,分期和非分期杂交手术之间没有差异。
杂交手术可以成功扩大适合后续 TEVAR 的患者范围。这些手术与孤立的肾下或胸主动脉腔内修复相比,并发症发生率更高,但考虑到这些患者的医疗和解剖复杂性,目前的结果相当令人鼓舞。